Paroxysmal slow cortical activity in Alzheimer's disease and epilepsy is associated with blood-brain barrier dysfunction.
Aged
Aging
/ pathology
Alzheimer Disease
/ physiopathology
Animals
Blood-Brain Barrier
/ physiopathology
Cerebral Cortex
/ physiopathology
Dementia
/ physiopathology
Electroencephalography
Epilepsy
/ physiopathology
Humans
Male
Mice
Nerve Net
/ physiopathology
Perfusion
Rats
Serum Albumin
/ metabolism
Journal
Science translational medicine
ISSN: 1946-6242
Titre abrégé: Sci Transl Med
Pays: United States
ID NLM: 101505086
Informations de publication
Date de publication:
04 12 2019
04 12 2019
Historique:
received:
04
02
2019
revised:
13
07
2019
accepted:
09
10
2019
entrez:
6
12
2019
pubmed:
6
12
2019
medline:
12
9
2020
Statut:
ppublish
Résumé
A growing body of evidence shows that epileptic activity is frequent but often undiagnosed in patients with Alzheimer's disease (AD) and has major therapeutic implications. Here, we analyzed electroencephalogram (EEG) data from patients with AD and found an EEG signature of transient slowing of the cortical network that we termed paroxysmal slow wave events (PSWEs). The occurrence per minute of the PSWEs was correlated with level of cognitive impairment. Interictal (between seizures) PSWEs were also found in patients with epilepsy, localized to cortical regions displaying blood-brain barrier (BBB) dysfunction, and in three rodent models with BBB pathology: aged mice, young 5x familial AD model, and status epilepticus-induced epilepsy in young rats. To investigate the potential causative role of BBB dysfunction in network modifications underlying PSWEs, we infused the serum protein albumin directly into the cerebral ventricles of naïve young rats. Infusion of albumin, but not artificial cerebrospinal fluid control, resulted in high incidence of PSWEs. Our results identify PSWEs as an EEG manifestation of nonconvulsive seizures in patients with AD and suggest BBB pathology as an underlying mechanism and as a promising therapeutic target.
Identifiants
pubmed: 31801888
pii: 11/521/eaaw8954
doi: 10.1126/scitranslmed.aaw8954
pii:
doi:
Substances chimiques
Serum Albumin
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : CIHR
ID : 366355
Pays : Canada
Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.